Literature DB >> 717928

Subacute fluorosis: a consequence of abuse of an organofluoride anesthetic.

P J Klemmer, N M Hadler.   

Abstract

A young woman presented with a novel multisystem disease: painful periostitis, osteosclerosis, hypertension, and renal dysfunction. The similarity of some of this clinical picture to fluoride intoxication led to the discovery of massively elevated fluoride levels in serum, urine, and bone. Although initially an enigma, the source of fluoride was later found to be the illicit use of an anesthetic agent, methoxyflurane. This agents is one of a class of organofluorides that, by virtue of biotransformation, is a known cause of inorganic fluoride exposure. Though the drug is potentially nephrotoxic as generally used, exposure to it is transient and has not previously led to discernible bone disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 717928     DOI: 10.7326/0003-4819-89-5-607

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

Review 1.  Medication-induced periostitis in lung transplant patients: periostitis deformans revisited.

Authors:  Lina Chen; Michael E Mulligan
Journal:  Skeletal Radiol       Date:  2010-07-22       Impact factor: 2.199

2.  Skeletal Fluorosis Due To Inhalation Abuse of a Difluoroethane-Containing Computer Cleaner.

Authors:  Joseph R Tucci; Gary M Whitford; William H McAlister; Deborah V Novack; Steven Mumm; Tony M Keaveny; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2016-10-14       Impact factor: 6.741

Review 3.  Non-endemic skeletal fluorosis: Causes and associated secondary hyperparathyroidism (case report and literature review).

Authors:  Fiona J Cook; Maighan Seagrove-Guffey; Steven Mumm; Deborah J Veis; William H McAlister; Vinieth N Bijanki; Deborah Wenkert; Michael P Whyte
Journal:  Bone       Date:  2021-01-06       Impact factor: 4.398

Review 4.  The role of inhaled methoxyflurane in acute pain management.

Authors:  Keith M Porter; Anthony D Dayan; Sara Dickerson; Paul M Middleton
Journal:  Open Access Emerg Med       Date:  2018-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.